Plain-English translation of NCT07038343 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is one of the first times this treatment has been tested in people.
This is an early-stage clinical trial testing a new medication called for people with advanced cancers that have spread or cannot be completely removed by surgery. The study will first find the right dose of the medication and check if it is safe, then test whether it actually helps shrink tumors—either as a single treatment or combined with other therapies.
Many advanced cancers still need better treatment options. This trial exists to find out whether this new medication could offer patients a new way to fight their cancer, either on its own or when combined with existing treatments.
You likely qualify if…
You likely don't qualify if…
If you join, you will receive the medication through an IV infusion during regular study visits at a cancer center. The trial has two main phases: first, researchers will gradually increase doses to find the safest amount, then expand to larger groups to see how well the treatment works. You may receive the medication alone or combined with other therapies, depending on which group you are in, and you will have frequent blood tests, scans, and check-ins to monitor your health and how you respond.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States